Literature DB >> 25582679

A case report comparing clinical, imaging and neuropsychological assessment findings in twins discordant for the VCP p.R155C mutation.

Abhilasha Surampalli1, Brian T Gold2, Charles Smith3, Rudy J Castellani4, Manaswitha Khare1, Hon Yu5, Celeste Nguyen6, Mary Lan1, Marie Wencel1, Sharon Wigal6, Vince Caiozzo7, Virginia Kimonis8.   

Abstract

Inclusion body myopathy, Paget disease of bone and/or frontotemporal dementia is an autosomal dominant disease caused by mutations in the Valosin Containing Protein (VCP) gene. We compared clinical findings including MRI images and neuropsychological assessment data in affected and unaffected twin brothers aged 56 years from a family with the p.R155C VCP gene mutation. The affected twin presented with a 10 year history of progressive proximal muscle weakness, difficulty swallowing, gastroesophageal reflux, fecal incontinence, and peripheral neuropathy. Comprehensive neuropsychological testing revealed rapid cognitive decline in the absence of any behavioral changes in a span of 1 year. This case illustrates that frontotemporal dementia related cognitive impairment may precede behavioral changes in VCP disease as compared with predominance of behavioral impairment reported in previous studies. Our findings suggest that there is a need to establish VCP disease specific tools and normative rates of decline to detect pre-clinical cognitive impairment among affected individuals.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Frontotemporal dementia screening; Inclusion body myopathy; Multisystem proteinopathy; Neuropsychological assessment; VCP

Mesh:

Substances:

Year:  2014        PMID: 25582679      PMCID: PMC5591024          DOI: 10.1016/j.nmd.2014.10.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  36 in total

1.  Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings.

Authors:  Kishore R Kumar; Merrilee Needham; Kym Mina; Mark Davis; Janice Brewer; Christopher Staples; Karl Ng; Carolyn M Sue; Frank L Mastaglia
Journal:  Neuromuscul Disord       Date:  2010-03-23       Impact factor: 4.296

2.  Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.

Authors:  M J Kovach; B Waggoner; S M Leal; D Gelber; R Khardori; M A Levenstien; C A Shanks; G Gregg; M T Al-Lozi; T Miller; W Rakowicz; G Lopate; J Florence; G Glosser; Z Simmons; J C Morris; M P Whyte; A Pestronk; V E Kimonis
Journal:  Mol Genet Metab       Date:  2001-12       Impact factor: 4.797

3.  Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.

Authors:  Mark S Forman; Ian R Mackenzie; Nigel J Cairns; Eric Swanson; Philip J Boyer; David A Drachman; Bharati S Jhaveri; Jason H Karlawish; Alan Pestronk; Thomas W Smith; Pang-Hsien Tu; Giles D J Watts; William R Markesbery; Charles D Smith; Virginia E Kimonis
Journal:  J Neuropathol Exp Neurol       Date:  2006-06       Impact factor: 3.685

Review 4.  Contemporary approaches to Alzheimer's disease and frontotemporal dementia.

Authors:  Erik D Roberson
Journal:  Methods Mol Biol       Date:  2011

5.  Development of a brief screening instrument: the HANDS.

Authors:  L Baer; D G Jacobs; J Meszler-Reizes; M Blais; M Fava; R Kessler; K Magruder; J Murphy; B Kopans; P Cukor; L Leahy; J O'Laughlen
Journal:  Psychother Psychosom       Date:  2000       Impact factor: 17.659

6.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

Review 7.  Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.

Authors:  Conrad C Weihl; Alan Pestronk; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-04-19       Impact factor: 4.296

8.  A screening assessment of cognitive impairment in patients with ALS.

Authors:  Paul H Gordon; Yuanjia Wang; Carolyn Doorish; Melissa Lewis; Vanessa Battista; Hiroshi Mitsumoto; Karen Marder
Journal:  Amyotroph Lateral Scler       Date:  2007-07-30

Review 9.  VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder.

Authors:  Virginia E Kimonis; Erin Fulchiero; Jouni Vesa; Giles Watts
Journal:  Biochim Biophys Acta       Date:  2008-09-18

10.  Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.

Authors:  Jouni Vesa; Hailing Su; Giles D Watts; Sabine Krause; Maggie C Walter; Barbara Martin; Charles Smith; Douglas C Wallace; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-10-13       Impact factor: 4.296

View more
  1 in total

Review 1.  Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia.

Authors:  Alberto Benussi; Alessandro Padovani; Barbara Borroni
Journal:  Front Aging Neurosci       Date:  2015-09-01       Impact factor: 5.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.